Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

thrombosis

Inflammation Markers May Refine Thrombosis Risk

Investigators describe this as the largest study to date linking thromboinflammation biomarkers with thrombosis risk in myeloproliferative neoplasms.

Inflammation Fuels Blood Cancer Progression

Inflammatory molecules circulating in the blood may worsen disease symptoms and points to new opportunities for targeted therapy.

Unwrapped 2025

Unwrap the Best of Hematology

It’s time for Unwrapped 2025. Explore Hematology’s defining moments, our Word of the Year, and a challenging brain teaser.

biopsy

Steroids Can Be Used Safely Before Lymphoma Biopsy

Doctors may not need to avoid steroids before biopsy in patients with a common aggressive lymphoma, according to a new study.

Hema Now Highlights pt 2

Hema Now: Episode 31: Year Wrap Up - Part 2

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

A Patient-Clinician Dialogue on Haemophilia Care

We are delighted to share a special haematology roundtable exploring a clinician–patient dialogue on haemophilia care, featuring…

Sponsored Content: Optimal Care of Unfit Patients with FTL3+ AML

This publication is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd.

sickle cell

Experts Set New Standards to Improve Sickle Cell Care

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with sickle cell disease.

Loading posts...

« Previous 1 2 3 4 5 6 … 100 Next »